These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35094881)

  • 1. Vaccination strategies and transmission of COVID-19: Evidence across advanced countries.
    Kim D; Lee YJ
    J Health Econ; 2022 Mar; 82():102589. PubMed ID: 35094881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021.
    Steele MK; Couture A; Reed C; Iuliano D; Whitaker M; Fast H; Hall AJ; MacNeil A; Cadwell B; Marks KJ; Silk BJ
    JAMA Netw Open; 2022 Jul; 5(7):e2220385. PubMed ID: 35793085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis.
    Hogan AB; Winskill P; Watson OJ; Walker PGT; Whittaker C; Baguelin M; Brazeau NF; Charles GD; Gaythorpe KAM; Hamlet A; Knock E; Laydon DJ; Lees JA; Løchen A; Verity R; Whittles LK; Muhib F; Hauck K; Ferguson NM; Ghani AC
    Vaccine; 2021 May; 39(22):2995-3006. PubMed ID: 33933313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the transition of COVID-19 burden towards the young population while vaccines are rolled out in China.
    Cai J; Yang J; Deng X; Peng C; Chen X; Wu Q; Liu H; Zhang J; Zheng W; Zou J; Zhao Z; Ajelli M; Yu H
    Emerg Microbes Infect; 2022 Dec; 11(1):1205-1214. PubMed ID: 35380100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing two-dose vaccine resource allocation to combat a pandemic in the context of limited supply: The case of COVID-19.
    Zhu J; Wang Q; Huang M
    Front Public Health; 2023; 11():1129183. PubMed ID: 37168073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the best time interval between doses in a two-dose vaccination regimen to reduce the number of deaths in an ongoing epidemic of SARS-CoV-2.
    Souto Ferreira L; Canton O; da Silva RLP; Poloni S; Sudbrack V; Borges ME; Franco C; Marquitti FMD; de Moraes JC; Veras MASM; Kraenkel RA; Coutinho RM
    PLoS Comput Biol; 2022 Mar; 18(3):e1009978. PubMed ID: 35333872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intention to vaccinate against COVID-19 and adherence to non-pharmaceutical interventions against COVID-19 prior to the second wave of the pandemic in Uganda: a cross-sectional study.
    Wafula ST; Mugume IB; Sensasi B; Okware S; Chimbaru A; Nanyunja M; Talisuna A; Kabanda R; Bakyaita T; Wanyenze RK; Byakika-Tusiime J
    BMJ Open; 2022 Jun; 12(6):e057322. PubMed ID: 35654469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India.
    Du Z; Wang L; Pandey A; Lim WW; Chinazzi M; Piontti APY; Lau EHY; Wu P; Malani A; Cobey S; Cowling BJ
    Nat Med; 2022 May; 28(5):934-938. PubMed ID: 35210596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-vaccination outcomes in association with four COVID-19 vaccines in the Kingdom of Bahrain.
    AlQahtani M; Du X; Bhattacharyya S; Alawadi A; Al Mahmeed H; Al Sayed J; Justman J; El-Sadr WM; Hidary J; Mukherjee S
    Sci Rep; 2022 Jun; 12(1):9236. PubMed ID: 35654940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness and durability of COVID-19 vaccination against death and severe disease in an ongoing nationwide mass vaccination campaign.
    Lytras T; Kontopidou F; Lambrou A; Tsiodras S
    J Med Virol; 2022 Oct; 94(10):5044-5050. PubMed ID: 35701379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-country evidence on the role of national governance in boosting COVID-19 vaccination.
    Aida T; Shoji M
    BMC Public Health; 2022 Mar; 22(1):576. PubMed ID: 35321676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward.
    Lawal L; Aminu Bello M; Murwira T; Avoka C; Yusuf Ma'aruf S; Harrison Omonhinmin I; Maluleke P; Tsagkaris C; Onyeaka H
    Hum Vaccin Immunother; 2022 Dec; 18(1):2034457. PubMed ID: 35240908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomy of the first six months of COVID-19 vaccination campaign in Italy.
    Gozzi N; Chinazzi M; Davis JT; Mu K; Pastore Y Piontti A; Ajelli M; Perra N; Vespignani A
    PLoS Comput Biol; 2022 May; 18(5):e1010146. PubMed ID: 35613248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of COVID-19 vaccination campaigns accounting for antibody-dependent enhancement.
    Adil Mahmoud Yousif N; Tsoungui Obama HCJ; Ngucho Mbeutchou YJ; Kwamou Ngaha SF; Kayanula L; Kamanga G; Ibrahim TB; Bwanu Iliya P; Iyanda S; Alawam Nemer L; Helle KB; Teboh-Ewungkem MI; Schneider KA
    PLoS One; 2021; 16(4):e0245417. PubMed ID: 33886573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.